Navigation Links
DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Release of New Pretrial Order in New Jersey DePuy ASR Recall Litigation
Date:8/7/2013

New York, New York (PRWEB) August 07, 2013

Lawsuits filed in the wake of the 2010 DePuy ASR recall (http://www.depuy-asr-hip-recall.com/) continue to move forward in a Multicounty Litigation now underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Pretrial Order issued on July 26th, the court has established deadlines for submission of proposed jury questionnaires, verdict forms and jury instructions for the litigation’s first bellwether trial. Among other things, the Order also stipulates that any motions for dismissal or summary judgment must be filed with the Court by September 17th. The Order sets a Pretrial Conference for October 8th, with the trial scheduled to get underway on October 21, 2013. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11)

“We are representing hundreds of clients in DePuy ASR lawsuits. This trial, along with the bellwether trial scheduled to begin next month in the federal multidistrict litigation, are important steps forward in the litigation and could provide clues as to how juries might weigh evidence in similar cases,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Lawsuits
According to the U.S. Food & Drug Administration, a worldwide recall was announced in August 2010 for DePuy ASR hip implants, after the metal-on-metal devices were found to be failing prematurely in an unexpectedly high number of recipients. Since then, Johnson & Johnson and its DePuy Orthopaedics unit have been named in more than 11,000 DePuy ASR lawsuits, all of which allege that toxic metal debris shed from the device caused plaintiffs to suffer metallosis, premature device failure and other serious complications that in some cases resulted in revision surgery. Bernstein Liebhard LLP is representing hundreds of DePuy ASR clients in a federal multidistrict litigation now underway in U.S. District Court, Northern District of Ohio. Court documents indicate the first bellwether trial in that proceeding will begin on September 9, 2013. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

Earlier this year, two DePuy ASR trials concluded in California and Illinois state courts. In March, a Los Angeles Superior Court jury found that the ASR was defectively designed, and awarded more than $8 million to the Plaintiff in that case. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County). A month later, a jury hearing a case in Chicago found for DePuy and Johnson & Johnson. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County)

Recipients of the DePuy ASR hip who suffered premature device failure, metallosis, or other serious complications may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. Learn More about filing a DePuy ASR lawsuit by visiting Bernstein Liebhard LLP’s website. For a free case review, please contact one of our attorneys by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.depuy-asr-hip-recall.com/

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-asr-recall/prweb11007219.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Lawsuit News: Rottenstein Law Group LLP Comments on Judge’s Decision to Exclude 2010 ASR Recall from Trial
2. DePuy Pinnacle Hip Lawsuit Filings in Federal Multidistrict Litigation Exceed 4,600, Bernstein Liebhard LLP Reports
3. DePuy Hip Class I Recall Announced By FDA of Its DePuy LPS Lower Extremity Dovetail Intercalary Hip Implant Component Due to Risk of Fracturing, Reports Wright & Schulte
4. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes DePuy Orthopaedic’s Motion for Summary Judgment in California Bellwether Case
5. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy Pinnacle Hip Litigation
6. US Drug Watchdog Now Urges All DePuy ASR Recalled Metal Hip Implant Recipients In The Remaining States To Call Them Immediately If They Have Not Yet Been Identified
7. US Drug Watchdog Now Warns Recipients Of A Recalled DePuy ASR Hip Implant About Statute Of Limitations Deadline To Get Identified And Urges Recipients To Call Them
8. California Judge Allows Plaintiffs in DePuy ASR Litigation to Combine DePuy Pinnacle Claims, Parker Waichman LLP Notes
9. DePuy Hip Replacement Lawsuit News: California Judge Allows DePuy ASR Lawsuit Plaintiffs to Add Pinnacle Hip Claims
10. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them About A Vital Blood Test That Should Reveal A Premature Failure
11. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them For The Name Of A Special Blood Test That Will Determine A Premature Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology: